Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
18%
OVERLAP
BY WEIGHT
16
# OF OVERLAPPING
HOLDINGS
SBIO
87
HOLDINGS
20%
ALSO IN XPH
XPH
60
HOLDINGS
27%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
CRINETICS PHARMACEUTICALS INC | 4.7% | 3.7% | 3.7% |
|
DEFINIUM THERAPEUTICS INC | 2.5% | 2.8% | 2.5% |
|
EDGEWISE THERAPEUTICS, INC. | 2.4% | 1.9% | 1.9% |
|
MBX BIOSCIENCES INC | 1.6% | 3.0% | 1.6% |
|
TARSUS PHARMACEUTICALS, INC. | 1.4% | 1.5% | 1.4% |
SBIO Overweight Relative to XPH
|
APOGEE THERAPEUTICS, INC. | 4.5% |
|
CG ONCOLOGY, INC. | 3.3% |
|
DIANTHUS THERAPEUTICS INC | 3.0% |
|
ORUKA THERAPEUTICS INC | 3.0% |
|
TRAVERE THERAPEUTICS, INC. | 2.9% |
|
ACADIA PHARMACEUTICALS INC | 2.3% |
|
DYNE THERAPEUTICS INC | 2.2% |
|
RELAY THERAPEUTICS, INC. | 2.2% |
|
DENALI THERAPEUTICS INC. | 2.0% |
|
NEWAMSTERDAM PHARMA CO NV | 1.9% |
SBIO Underweight Relative to XPH
|
ENLIVEN THERAPEUTICS, INC. | -2.2% |
|
ALUMIS INC | -2.1% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.0% |
|
TREVI THERAPEUTICS, INC. | -2.0% |
|
CORCEPT THERAPEUTICS INC | -1.9% |
|
LIGAND PHARMACEUTICALS-CL B | -1.8% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -1.8% |
|
BRISTOL-MYERS SQUIBB CO | -1.7% |
 |
JAZZ PHARMACEUTICALS PLC | -1.7% |
|
PACIRA PHARMACEUTICALS INC | -1.7% |